Aachen, Germany

Ulrich G Seipp

This inventor holds 6 USPTO granted patents. Top assignee: Gruenenthal Gmbh. Active years: 1983-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ulrich G Seipp. Retrieved from https://idiyas.com/inventor/ulrich-g-seipp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 83.3

Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 1983-2003

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Ulrich G Seipp: Innovator in Pharmaceutical Chemistry

Introduction

Ulrich G Seipp is a notable inventor based in Aachen, Germany. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 6 patents. His work focuses on innovative compounds that have potential applications in medicine.

Latest Patents

Among his latest patents, Seipp has developed methods for the use of catechol derivatives as proteinase inhibitors. Additionally, he has worked on oxyalkyne compounds and pharmaceutical compositions containing them. These compounds are characterized by specific structural formulas that include various substituents, making them suitable active ingredients in pharmaceutical compositions.

Career Highlights

Seipp is currently associated with Grünenthal GmbH, a company known for its commitment to developing innovative pain management solutions. His work at the company has been instrumental in advancing pharmaceutical research and development.

Collaborations

Throughout his career, Seipp has collaborated with esteemed colleagues such as Werner P Vollenberg and Werner Guenter Englberger. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Ulrich G Seipp's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in medicine. His patents and collaborations continue to influence the development of new therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…